Chi Sheng Pharma & Biotech (4111.TWO) Earnings Analysis
Chi Sheng Pharma & Biotech (4111.TWO) next reports earnings on 2026-08-06, consensus EPS 0.3714 TWD. Last quarter (2026-03-13) it beat with EPS 0.76 TWD vs 0.543 TWD est (+40%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 9.97.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4111.TWO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.3714 TWD |
| Revenue estimate | 0.26B |
4111.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-13 | 0.76 TWD | 0.543 TWD | +40% | Beat |
| 2025-08-08 | 0.61 TWD | n/a | n/a | n/a |
| 2025-03-14 | 0.814 TWD | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
4111.TWO valuation and analyst view
| Trailing P/E | 9.97 |
|---|---|
| Trailing EPS | 2.999 TWD |
| Price / book | 1.26 |
| Dividend yield | 3.32% |
| Market cap | 1.79B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Chi Sheng Pharma & Biotech (4111.TWO)'s next earnings date?
Chi Sheng Pharma & Biotech is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.3714 TWD and revenue estimate of 0.26B.
Did 4111.TWO beat earnings last quarter?
In its 2026-03-13 report, 4111.TWO posted EPS of 0.76 TWD versus a 0.543 TWD estimate — a beat of 40%.
What is 4111.TWO's earnings track record?
Over the last 1 reported quarters with consensus data, 4111.TWO beat estimates 1 times (100%).
What is 4111.TWO's current P/E ratio and EPS?
4111.TWO trades at a trailing P/E of 9.97 on trailing EPS of 2.9987464901724827 TWD.
What do analysts rate 4111.TWO?
4111.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.